A therapeutic hpv vaccine based on validated target epitopes
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsAngelika RIEMER, Maria Brauer, Jonas FÖRSTER, Jonas BECKER
Life of this patent
Estimating the term…
Abstract
The present invention relates to a vaccine against a human papillomavirus 16 (HPV16)-related virus providing at least six discrete immunization peptides consisting of the amino acid sequences of SEQ ID NOs:1 to 6, wherein said vaccine comprises a mixture of discrete peptides each comprising exactly one of said amino acid sequences; and to the vaccine for use in medicine and in eliciting an immune response in a human subject against HPV infection, as well as a kit related thereto.
Claims15
A vaccine against a human papillomavirus 16 (HPV16)-related virus providing at least six discrete immunization peptides consisting of the amino acid sequences of SEQ ID NOs:1 to 6, wherein said vaccine comprises a mixture of discrete peptides each comprising exactly one of said amino acid sequences.
(canceled)
Dependencies are inferred from the claim text.